WednesdayMar 29, 2023 12:23 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in Upcoming Virtual Investor Event

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be presenting at an upcoming Virtual Investor GBM Spotlight Event. The online event is scheduled for April 4, 2023, at 4:30 p.m. ET. The event will include a live, moderated video webcast with members of CNS Pharmaceuticals management, including CEO John Climaco; the panel will also include key opinion leader, Michael Weller, MD. Weller is an acclaimed neuro-oncologist who currently serves as chair of the Department of Neurology at the University Hospital in Zurich,…

Continue Reading

MondayMar 27, 2023 12:30 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) to Host Town Hall Marathon

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, today announced its plans to hold 10 Town Halls during the first 10 days of April 2023. The event series is in celebration of Knightscope’s 10 year anniversary and following the filing of its 10-K annual report. The announcement reads, “Similar to numerous prior Town Halls hosted by the company over the years, Knightscope’s Chairman and CEO, William Santana Li, will be available to answer questions from supporters, investors and analysts in an intimate online forum with no moderator. In order to accommodate busy…

Continue Reading

FridayMar 24, 2023 1:45 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Board-Approved Action to Regain Compliance with NASDAQ Market Requirements

Freight Technologies (NASDAQ: FRGT), a technology company offering its custom-developed Fr8App, has announced a reverse share split. The move is designed to increase the market price per share of the company’s ordinary share, thereby resulting in Freight Technologies regaining compliance with NASDAQ’s minimum bid price requirement and maintaining its NASDAQ Capital Market listing. FRGT board of directors approved the 10:1 reverse split on March 3, 2023; the split will be effective on or around March 24, 2023. According to the announcement, the company’s ordinary shares will continue to trade on NASDAQ under the symbol FRGT but will trade under a new…

Continue Reading

FridayMar 24, 2023 12:33 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Efforts to Boost Commercial Prospects ‘Paying off in Spades’

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator developing and commercializing its patented DehydraTECH(TM) drug delivery technology. Lexaria is continuing and/or initiating discussions with several larger companies in Europe and North America regarding the licensed use of its technology for both consumer and pharmaceutical sectors. “The materialization of such partnerships hinges on a number of must-haves. Firstly, there must be a tangible product that draws larger companies. Secondly, The decision of whether or not to invest, and the scale of any investment, is based on how well the technologies that form the core of a company have been protected.…

Continue Reading

ThursdayMar 23, 2023 1:30 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Receives Order from Florida University, Notes Media Day Spotlighting OCCC’s New Robot

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has received an order for three of its K1 Blue Light Emergency Phones from a southern Florida university. The order was placed through Transportation Solutions & Lighting, a Florida-based reseller of Knightscope technologies that previously ordered 40 K1 Blue Light Towers in order to supply growing demand for emergency communications solutions. A compact version of the familiar blue-light towers often found in parking lots and campuses across the United States, KSCP’s K1 Blue Light Emergency Phone offering is a perfect way to provide added…

Continue Reading

WednesdayMar 22, 2023 11:00 am

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Eyes Continued Growth in Cross-Border and Domestic FTL Offerings

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), an over-the-road shipping technology innovator, is dedicated to keeping freight moving around the country and between the United States’ primary land-based trading partners in an efficiently designed and successful manner. The company does this using its flagship AI-powered Fr8App B2B marketplace as a powerful tool. “Fr8Tech recently announced its market guidance data, projecting revenues of between $36 million and $42 million for 2023, which will be an increase over 2022’s preliminary revenue figures of approximately $26 million to $27 million. The company’s projections for revenue growth are underscored by the comments President Biden made during…

Continue Reading

TuesdayMar 21, 2023 1:35 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Adds to Growing Orders, Marks 75th Stop in Robot Roadshow Schedule

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has received three new orders from its K1 emergency communication suite of products. According to the company, a New Hampshire university purchased a Knightscope K1 Retrofit Kit to test the product with plans to order additional kits upon successful completion of the testing. The other two orders came from the Borough of Carteret Police Department in New Jersey, which purchased two K1 Blue Light Towers for use in a community local park, and the Port Authority NY NJ, which added an additional six K1…

Continue Reading

TuesdayMar 21, 2023 1:02 pm

TinyGemsBreaks — Cepton Inc. (NASDAQ: CPTN) Announces CEO’s Panel Participation in Upcoming EV/Auto Tech Virtual Conference

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, will be represented at the upcoming at the Maxim Group Electric Vehicle & Auto Tech Virtual Conference. The company announced that its CEO, Dr. Jun Pei, will be part of a panel discussion during the online event, which is slated for March 30, 2023. Pei will be part of a panel that will take a close look at ADAS/AV sensor technologies; the panel is scheduled to begin at 11:30 a.m. ET on March 30. To view the panel discussion, visit https://ibn.fm/Q5xrm   To view the full press release,…

Continue Reading

MondayMar 20, 2023 3:22 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Enters Licensing Agreement with Qiantu Motors to Manufacture, Distribute EV Supercar

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is partnering with Qiantu Motors to launch the DragonFLY K50 in the Americas. As part of an exclusive licensing agreement, Qiantu Motors and affiliated companies granted MULN the North and South American IP and distribution rights allowing assembly and distribution. The announcement noted that Mullen will finalize vehicle engineering in compliance with U.S. regulations with final assembly planned for its Indiana-based manufacturing facility. The EV supercar will be sold under the Mullen GT & GTRS brands with performance specs anticipated to include going from 0 to 60 miles per hour…

Continue Reading

FridayMar 17, 2023 1:28 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Moving Closer to Providing Alternative Hypertension Treatment with DehydraTECH(TM)-CBD

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently reported additional findings from its most comprehensive clinical study yet, HYPER-H21-4. “The findings showed that DehydraTECH-CBD resulted in a statistically significant reduction in average baseline serum catestatin concentrations of 13.50 ng/mL to just 9.65 ng/mL after five weeks of dosing, representing a 28.5% drop. In addition, mean arterial pressure significantly dropped by 4.26 ± 1.26 mm/Hg following the five weeks of DehydraTECH-CBD dosing. No statistically significant reductions in catestatin concentrations were identified in the placebo group,” a recent article reads. “Given the growing demand for alternative anti-hypertensive…

Continue Reading

Contact us: (512) 354-7000